A comparison of three gonadotrophin-releasing hormone analogues in an in-vitro fertilization programme: A prospective randomized study

Human Reproduction

Volumn 14, Issue 2, 1999, Pages 288-293

  Dada, T ^a   Salha, O ^a   Baillie, H S ^a   Sharma, V ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

GnRHa; Hormonal suppression; IVF; Pregnancy

Indexed keywords

BUSERELIN; ESTRADIOL; GONADORELIN; GONADOTROPIN; HORMONE RELEASE INHIBITING FACTOR; LEUPRORELIN; NAFARELIN; UNCLASSIFIED DRUG; UROFOLLITROPIN;

ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; FOLLICULAR PHASE; HORMONE RELEASE; HUMAN; INFERTILITY; INTRANASAL DRUG ADMINISTRATION; LUTEAL PHASE; MAJOR CLINICAL STUDY; NIDATION; PREGNANCY RATE; PROSPECTIVE STUDY; SPONTANEOUS ABORTION; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0032978185     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/14.2.288     Document Type: Article

References (40)

1. Abdalla, H.I., Ahuiakk, L.T., Morris, N.N. et al. (1990) Comparative trial of luteinising-hormone releasing hormone analogue/human menopausal gonadotrophin in an assisted conception program. Fertil. Steril., 53, 473-478.
2. Assisted Conception Unit (1997) Annual Report. St James's University Hospital, Leeds, UK. pp. 2-7.
3. Awadalla, S.G., Friedman, C.I., Chin, N.W. et al. (1987) Follicular stimulation for in vitro fertilisation using pituitary suppression and human menopausal gonadotrophins. Fertil. Steril., 48, 811-814.
4. Balasch, J., Jové, C.I., Moreno, V. et al. (1992) The comparison of two gonadotrophin-releasing hormone agonists in an in vitro fertilization program. Fertil. Steril., 58, 991-994.
5. Belaisch-Allart, J., Testait, J. and Frydman, R. (1988) Utilisation of GnRHa for poor responders in an IVF programme. Hum. Reprod., 4, 33-34.
6. Ben-Rafael, Z., Menashe, Y., Mimon, R. et al. (1990) Limitations in the use of combined gonadotrophin releasing hormone analog and human menopausal gonadotrophin for in vitro fertilisation. In Maschiach, S., Ben-Rafael, Z., Laufer, N. and Schenker, J.G. (eds), Advances in Assisted Reproductive Technologies. Plenum Press, New York, pp. 17-30.
7. Bourgain, C., Smitz, J., Camus, M. et al. (1994) Human endometrial maturation is markedly improved after luteal supplementation of gonadotrophin-releasing hormone analogue/human menopausal gonadotrophin stimulated cycles. Hum. Reprod., 9, 32-40.
8. Broekmans, F.J., Bernardus, R.E., Berkhout, G. and Shoemaker, J. (1992) Pituitary and ovarian suppression after early follicular and mid-luteal administration of a LHRH agonist in a depot formation: decapeptyl CR. Gynaecol. Endocrinol., 6, 153-161.
9. Daya, S. (1993) Short versus long protocol using gonadotrophin releasing hormone agonists (GnRHa) for in virro fertilization cycles - a meta-analysis. American Fertility Society Program Supplement, Abstracts of the Scientific Oral and Poster Session, 058, 11-14.
10. Filicori, M., Cognigni, G.E., Arnone, R. et al. (1996) Role of different GnRH agonist regimens in pituitary suppression and the outcome of controlled ovarian hyperstimulation. Hum. Reprod., 11 (Suppl. 3), 123-132.
11. Gartner, B., Moreno, C., Marinaro, A. et al. (1997) Accidental exposure to daily long-acting gonadotrophin-releasing hormone analogue administration and pregnancy in an in-vitro fertilisation cycle. Hum. Reprod., 12, 2557-2559.
12. Hughes, E.G., Ferdokow, D.M., Daya, S. et al. (1992) The routine use of gonadotrophin-releasing agonists prior to in vitro fertilisation and gamete intra-fallopian transfer: a meta-analysis of randomised controlled trials. Fertil. Steril., 58, 888-814.
13. Jenkins, J.M. (1996) The influence, development and management of functional ovarian cysts during IVF cycles. Hum. Reprod.. 11 (Suppl. 4), 132-136.
14. Jenkins, J.M., Davies, D.W., Anthony, F.W. et al. (1992) The detrimental influence of functional ovarian cysts during in-vitro fertilization cycles. Hum. Reprod., 7, 776-780.
15. Juha, T., Outi, H., Kaisa, J. et al. (1993) Subcutaneous goserelin versus intranasal buserelin for pituitary down-regulation in patients undergoing IVF: a randomized comparative study. Hum. Reprod., 8, 256-263.
16. Kerin, J.F. (1989) The advantages of a gonadotrophin releasing hormone agonist (leuprolide acetate) in conjunction with gonadotrophins for controlled ovarian hyperstimulation in IVF and GIFT cycles. Arch. Gynecol. Obstet., 246, S45-S52.
17. Leung, P.C.S., Lopata, A., Kellow, G.N. et al. (1983) Histochemical study of cumulus cells for assessing the quality of preovulatory oocytes. Fertil. Steril., 39, 853-855.
18. Lockwood, G.M., Pinkerton, S.M. and Barlow, D.H. (1995) A prospective randomised single blind comparative trial of nafarelin acetate with buserelin in long-protocol gonadotrophin-releasing hormone analogue controlled in vitro cycles. Hum. Reprod., 10. 293-298.
19. Loumaye, E. (1990) The control of endogenous secretion of LH by gonadotrophin-releasing hormone agonists during ovarian hyperstimulation for in-vitro fertilisation and embryo transfer. Hum. Reprod., 5, 357-376.
20. Loumaye, E., de Cooman, S., Anoma, M. et al. (1988) Short term utilisation of a gonadotrophin releasing hormone agonist (Buserelin) for induction of ovulation in an in vitro fertilization program. Ann. NY Acad. Sci., 541, 96-102.
21. Martin, M.C., Willman, S., Monroe, S.E. et al. (1992) Pretreatment with the GnRH agonist nafarelin acetate for in vitro fertilization. In Nafarelin -Recent Advances. Selected proceedings of the Second International Symposium on GnRH analogues in Cancer and Human Reproduction, Parthenon, Carnforth, UK, pp. 9-13.
22. Meldrum, D.R., Tsao, Z., Monroe, S.A. et al. (1984) Stimulation of LH fragments with reduced bio-activity following GnRH agonist administration in women. J. Clin Endocrinol. Metab., 58. 755-801.
23. Meldrum, D.R., Wisot, A., Hamilton, F. et al. (1988) Timing of initiation and dose schedule of leuprolide influence the time course of ovarian suppression. Fertil. Steril. 50, 400-402.
24. Meldrum, D.R., Wisot, A., Hamilton, F. et al.(1989) Routine pituitary suppression with leuprolide before ovarian stimulation for oocyte retrieval. Fertil. Steril., 51, 455-445.
25. Neveu, S., Hedon, B., Bringer, J. et al. (1987) Ovarian stimulation by a combination of gonadotrophin-releasing hormone agonist and gonadotropins for in vitro fertilisation. Fertil. Steril., 47, 639-643.
26. Penzias, A.S., Shamma, F.N., Gutmann, J.N. et al. (1992) Nafarelin versus leuprolide in ovulation induction for in vitro fertilisation: a randomised clinical trial. Obstet. Gynecol., 79, 739-742.
27. Porcu, E., Filicori, M., Dal Prato, L. et al. (1995) Comparison between depot leuprorelin and daily buserelin in IVF. J. Assist. Reprod. Genet., 12, 15-19.
28. Raga, F., Casa, E. M., Ruiz, A. et al. (1998) Gonadotrophin-releasing hormone agonist administered throughout the luteal phase and early pregnancy increases fecundity in IVF-embryo transfer patients. Hum. Reprod., 13 (Abstract Book), O-184, p 93.
29. Rivier, J., Jiang, G-C., Lahrichi, S.L. et al. (1996) Dose relationship between GnRH antagonists and pituitary suppression. Hum. Reprod., 11 (Suppl. 3), 133-147.
30. Ron-El, R., Herman, A., Golan, A. et al. (1990b) The comparison of early follicular and mid luteal administration of long acting gonadotrophin-releasing hormone agonist. Fertil. Steril., 54, 233-237.
31. Serafini, P., Stone, B., Kerin, J. et al. (1988) An alternative approach in controlled ovarian hyperstimulation in 'poor responders': pretreatment with a gonadotrophin-releasing hormone analog. Fertil. Steril., 49, 90-93.
32. Skarin, G., Nillius, S. J. and Wide, L. (1982) Failure to induce abortion by huge doses of LHRH agonist in women. Contraception, 26, 457-463.
33. Smitz, J., Devroey, P., Broekmans, P. et al. (1987) Management of failed cycles in an IVF/GIFT programme with the combination of a GnRH analog and hMG. Hum. Reprod., 2, 309-314.
34. Smitz, J., Ron-El, R. and Tarlatzis, B.C. (1992) The use of gonadotrophin releasing agonists for in vitro fertilisation and other assisted procreation techniques: experience from three centres. Hum. Reprod. (Suppl.), 7, 49-63.
35. Tan, S.L. (1996) Gonadotrophin-releasing hormone agonists in assisted reproductive therapy. Hum. Reprod., 11 (Suppl. 4), 137-142.
36. Tarlatzis, B.C., Grimbizis, G., Pournaropoulos, F. et al. (1994a) Evaluation of two gonadotrophin-releasing hormones (GnRHa) analogues (leuprolide and buserelin) in short and long protocols for assisted reproduction techniques. J. Assist. Reprod. Genet., 11, 85-91.
37. Tarlatzis, B.C., Bili, H., Boutis, J. et al. (1994b) Follicle cyst formation after administration of different gonadotrophin-releasing hormone analogues for assisted reproduction. Hum. Reprod. 9, 1983-1986.
38. Testart, J., Lefevre, B. and Gongeon, A. (1993) Effects of gonadotrophin releasing hormone agonists, GnRHa on follicle and oocyte quality. Hum. Reprod., 8, 511-518.
39. Tolis, G., Comaru-Schally, A.M., Mehta, A.E. and Schally A.V. (1981) Failure to interrupt established pregnancy in humans by D-trytophan-6-luteinising hormone-releasing hormone. Fertil. Steril., 36, 241-242.
40. World Health Organization (1987) Laboratory Manual for the Examination of Human Semen and Semen-Cervical Mucus Interaction. Cambridge University Press, Cambridge, p. 27.